& let another pharmaceutical company have the rights to 5-HMF & "possibly" compete with Xechem for the SCD drug treatment market?Very smart move by Xechem IMO they simply can not let another drug company be able to use/have access to 5-HMF to treat SCD if they are going to be successful marketing Nicosan...by acquiring the rights to 5-HMF they remove any threat of someone using it to compete against Nicosan IMO...smart business move plus Nicosan works extremely well anyway..don't know enough about 5-HMF... maybe its better than Nicosan ?..then again ,maybe not?..the important thing is Xechem owns the rights to it.thats whats important. IMO...Kinda like big pharma paying off scientists for the rights to cancer treatment drugs that have shown to have[from Trudeau's natural cure book] worked EXTREMELY well against cancer..so well it might even put big pharma out of the cancer drug business??can't let that happen....
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.